Antimalarial activity of new acridinone derivatives

Malaria is one of the major threats concerning world public health. Resistance to the current antimalarial drugs has led to searches for new antimalarial compounds. Acridinone derivatives have recently demonstrated to be active against malaria parasite. We focused our attention on synthesized new ac...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Fernández-Calienes, A.
Otros Autores: Pellón, R., Docampo, M., Fascio, M., D'Accorso, N., Maes, L., Mendiola, J., Monzote, L., Gille, L., Rojas, L.
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2011
Materias:
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 11635caa a22012857a 4500
001 PAPER-10591
003 AR-BaUEN
005 20230518204039.0
008 190411s2011 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-79959676872 
024 7 |2 cas  |a atovaquone, 94015-53-9, 95233-18-4; chloroquine, 132-73-0, 3545-67-3, 50-63-5, 54-05-7; stigmatellin, 91682-96-1; Acridines; Antimalarials; Hemeproteins; hemozoin, 39404-00-7 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a BIPHE 
100 1 |a Fernández-Calienes, A. 
245 1 0 |a Antimalarial activity of new acridinone derivatives 
260 |c 2011 
270 1 0 |m Fernández-Calienes, A.; Departamento de Parasitología, Instituto de Medicina Tropical Pedro Kourí, Autopista Novia del Mediodía Km 6, Ciudad de La Habana, Marianao 13, Cuba; email: ayme@ipk.sld.cu 
506 |2 openaire  |e Política editorial 
504 |a (2008) World Malaria Report 2008, , http://apps.who.int/malaria/wmr2008/malaria2008.pdf, WHO, Geneva, [Online], World HealthOrganization 
504 |a Towie, N., Malaria breakthrough raises spectra of drug resistance (2006) Nature, 440, p. 852 
504 |a Meshnick, S.R., Taylor, T.E., Kamchonwongpaisan, S., Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy (1996) Microbiol Rev, 60, pp. 301-315 
504 |a Brewer, T.G., Genovese, R.F., Newman, D.B., Li, Q., Factors relating to neurotoxicity of artemisinin antimalarial drugs "listening to arteether" (1998) Med Trop (Mars), 58, pp. 22-27 
504 |a Clark, R.L., White, T.E.K., Clode, S.A., Gaunt, I., Winstanley, P., Ward, S.A., Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit. Birth Defects Res B Dev Reprod Toxicol 2004;71:380-94; Winter, R., Kelly, J.X., Smilkstein, M.J., Dodean, R., Bagby, G.C., Rathbun, R.K., Evaluation and lead optimization of antimalarial acridones (2006) Exp Parasitol, 114, pp. 47-56 
504 |a Kelly, J.X., Smilkstein, M.J., Cooper, R.A., Lane, K.D., Johnson, R.A., Janowsky, A., Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum (2007) Antimicrob Agents Chemother, 51, pp. 4133-4140 
504 |a Kelly, J.X., Smilkstein, M.J., Brun, R., Wittlin, S., Cooper, R.A., Lane, K.D., Discovery of dual function acridones as a new antimalarial chemotype (2009) Nature, 459, pp. 270-273 
504 |a Martin, S.K., Oduola, A.M., Milhous, W.K., Reversal of chloroquine resistance in Plasmodium falciparum by verapamil (1987) Science, 235, pp. 899-901 
504 |a Walker, M.A., A new approach for developing anti-malarial agents (2009) Drug Discov Today, 14, pp. 19-20 
504 |a Fascio, M.L., D'Accorso, N.B., Pellón, R.F., Docampo, M.L., Synthesis of novel carbohydrate acridinone derivatives with potential biological activities using 1,3-dipolar cycloaddition (2007) Synth Commun, 37, pp. 4209-4217 
504 |a Sepúlveda, C.S., Fascio, M.L., Mazzucco, M.B., Docampo, M.L., Pellón, R.F., García, C.C., Synthesis and evaluation of N-substituted acridones as antiviral agents against hemorrhagic fever viruses (2008) Antivir Chem Chemother, 19, pp. 41-47 
504 |a Pardo Andreu, G.L., Inada, N.M., Pellón, R.F., Docampo, M.L., Fascio, M.L., D'Accorso, N.B., New acridinone derivative with trypanocidal activity (2008) Int J Antimicrob Agents, 31, pp. 502-504 
504 |a Docampo, M.L., Pellón, R.F., Synthesis of N-phenylanthranilic acid derivatives using water as solvent in the presence of ultrasound irradiation (2003) Synth Commun, 33, pp. 1771-1775 
504 |a Cos, P., Vlietinck, A.J., Berghe, V., Maes, L., Anti-infective potential of natural products: How to develop a stronger in vitro "proof-of- concept" (2006) J Ethnopharmacol, 106, pp. 290-302 
504 |a Makler, M.T., Ries, J.M., Williams, J.A., Bancroft, J.E., Piper, R.C., Gibbins, B.L., Parasite lactate dehydogenase as an assay for Plasmodium falciparum drug sensitivity (1993) Am J Trop Med Hyg, 48, pp. 739-741 
504 |a Baelmans, R., Deharo, E., Muñoz, V., Sauvain, M., Ginsburg, H., Experimental conditions for testing the inhibitory activity of chloroquine on the formation of β-hematin (2000) Exp Parasitol, 96, pp. 243-248 
504 |a Ncokazi, K.K., Egan, T.J., A colorimetric high-throughput β-hematin inhibition screening assay for use in the search for antimalarial compounds (2005) Anal Biochem, 338, pp. 306-319 
504 |a Parapini, S., Basilico, N., Pasini, E., Egan, T.J., Olliaro, P., Taramelli, D., Monti, D., Standardization of the physiochemical parameters to assess in vitro the β-hematin inhibitory activity of antimalarial drugs (2000) Exp Parasitol, 96, pp. 249-256 
504 |a Lundblad, V., Struhl, K., Yeast (2003) Current protocols in molecular biology, pp. 13.0.1-13.0.3. , N. Y: John Wiley & Sons, Inc, Brooklyn, F.M. Ausubel (Ed.) 
504 |a Trembath, M.K., Tzagoloff, A., Large- and small-scale preparations of yeast mitochondria (1979) Meth Enzymol, 55, pp. 160-163 
504 |a Geier, B.M., Schagger, H., Brandt, U., Colson, A.M., von Jagow, G., Point mutation in cytochrome b of yeast ubihydroquinone:cytochrome-c oxidoreductase causing myxothiazol resistance and facilitated dissociation of the iron-sulfur subunit (1992) Eur J Biochem, 208, pp. 375-380 
504 |a Smith, A.L., Properties, and conditions for assay of mitochondria: slaughterhouse material, small scale (1962) Meth Enzymol, 10, pp. 81-86. , Preparation 
504 |a Schagger, H., Link, T.A., Engel, W.D., von, J.G., Isolation of the eleven protein subunits of the bc1 complex from beef heart (1986) Meth Enzymol, 126, pp. 224-237 
504 |a Gille, L., Stamberg, W., Jager, W., Reznicek, G., Netscher, T., Rosenau, T., A new ubiquinone metabolite and its activity at the mitochondrial bc(1) complex (2007) Chem Res Toxicol, 20, pp. 591-599 
504 |a Fujioka, H., Nishiyama, Y., Furukawa, H., Kumada, N., In vitro and in vivo activities of atalaphillinine and related acridone alkaloids against rodent malaria (1989) Antimicrob Agents Chemother, 33, pp. 6-9 
504 |a Waffo, A.F., Coombes, P.H., Crouch, N.R., Mulholland, D.A., El Amin, S.M., Smith, P.J., Acridone and furoquinoline alkaloids from Teclea gerrardii (Rutaceae: Toddaloideae) of southern Africa (2007) Phytochem, 68, pp. 663-667 
504 |a Nwaka, S., Ramirez, B., Brun, R., Maes, L., Douglas, F., Ridley, R., Advancing drug innovation for neglected Diseases- Criteria for lead progression (2009) PLoS NTD, 3, pp. e440 
504 |a Biagini, G.A., Fisher, N., Berry, N., Stocks, P.A., Meunier, B., Williams, D.P., Acridinediones: Selective and potent inhibitors of the malaria parasite mitochondrial bc1 complex (2008) Mol Pharmacol, 73, pp. 1347-1355 
504 |a Suswan, E., Kyle, D., Lang-Unnash, N., Plasmodium falciparum: the effects of atovaquone resistance on respiration (2001) Exp Parasitol, 98, pp. 180-187 
520 3 |a Malaria is one of the major threats concerning world public health. Resistance to the current antimalarial drugs has led to searches for new antimalarial compounds. Acridinone derivatives have recently demonstrated to be active against malaria parasite. We focused our attention on synthesized new acridinone derivatives, some of them resulting with high antiviral and trypanocidal activity. In this study new derivatives of 10-alyl-, 10-(3-methyl-2-butenyl)- and 10-(1,2-propadienyl)-9(10H)-acridinone were evaluated for their antimalarial activity against Plasmodium falciparum. To assess the selectivity, cytotoxicity was assessed in parallel against human MRC-5 cells. Inhibition of β-hematin formation was determined using a spectrophotometric assay. Mitochondrial bc 1 complexes were isolated from yeast and bovine heart cells to test acridinone inhibitory activity. This study resulted in the identification of three compounds with submicromolar efficacy against P. falciparum and without cytotoxic effects on human cellular line. One compound, IIa (1-fluoro-10-(3-methyl-2-butenyl)-9(10H)-acridinone), can be classified as hit for antimalarial drug development exhibiting IC 50 less than 0.2μg/mL with SI greater than 100. In molecular tests, no relevant inhibitory activity was obtained for our compounds. The mechanism of acridinones antimalarial action remains unclear. © 2011 Elsevier Masson SAS.  |l eng 
593 |a Departamento de Parasitología, Instituto de Medicina Tropical Pedro Kourí, Autopista Novia del Mediodía Km 6, Ciudad de La Habana, Marianao 13, Cuba 
593 |a Laboratorio de Síntesis Orgánica, Facultad de Química, Ciudad de La Habana, Universidad de La Habana, Calle Zapata s/n entre G y Carlitos Aguirre. Plaza, CP 10 400, Cuba 
593 |a CIHIDECAR (CONICET), Departamento de Química Orgánica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Pabellón 2, Piso 3, 1428 Buenos Aires, Argentina 
593 |a Laboratory for microbiology, Parasitology and hygiene (LMPH), University of Antwerp, Groenenborgerlaan 171, 2020 Antwerp, Belgium 
593 |a Molecular pharmacology and toxicology unit, Department of biomedical sciences, University of Veterinary Medicine, Veterinärpl. 1, 1210 Vienna, Austria 
690 1 0 |a ACRIDINONE 
690 1 0 |a ANTIMALARIAL ACTIVITY 
690 1 0 |a PLASMODIUM FALCIPARUM 
690 1 0 |a 10 (1,2 PROPADIENYL) 9 (10H) ACRIDINONE 
690 1 0 |a 10 (3 METHYL 2 BUTENYL) 9 (10H) ACRIDINONE 
690 1 0 |a 10 ALLYL 9 (10H) ACRIDINONE 
690 1 0 |a ANTIMALARIAL AGENT 
690 1 0 |a ATOVAQUONE 
690 1 0 |a BETA HEMATIN 
690 1 0 |a CHLOROQUINE 
690 1 0 |a HEME DERIVATIVE 
690 1 0 |a STIGMATELLIN 
690 1 0 |a UNCLASSIFIED DRUG 
690 1 0 |a ANIMAL CELL 
690 1 0 |a ANTIMALARIAL ACTIVITY 
690 1 0 |a ARTICLE 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a COW 
690 1 0 |a CYTOTOXICITY 
690 1 0 |a DRUG SELECTIVITY 
690 1 0 |a HEART MUSCLE CELL 
690 1 0 |a HUMAN 
690 1 0 |a HUMAN CELL 
690 1 0 |a IC 50 
690 1 0 |a NONHUMAN 
690 1 0 |a PLASMODIUM FALCIPARUM 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a SPECTROPHOTOMETRY 
690 1 0 |a YEAST 
690 1 0 |a ACRIDINES 
690 1 0 |a ANIMALS 
690 1 0 |a ANTIMALARIALS 
690 1 0 |a CATTLE 
690 1 0 |a CELL LINE 
690 1 0 |a DRUG RESISTANCE, MICROBIAL 
690 1 0 |a HEMEPROTEINS 
690 1 0 |a HUMANS 
690 1 0 |a PLASMODIUM FALCIPARUM 
690 1 0 |a YEASTS 
650 1 7 |2 spines  |a MALARIA 
700 1 |a Pellón, R. 
700 1 |a Docampo, M. 
700 1 |a Fascio, M. 
700 1 |a D'Accorso, N. 
700 1 |a Maes, L. 
700 1 |a Mendiola, J. 
700 1 |a Monzote, L. 
700 1 |a Gille, L. 
700 1 |a Rojas, L. 
773 0 |d 2011  |g v. 65  |h pp. 210-214  |k n. 3  |p Biomed. Pharmacother.  |x 07533322  |t Biomedicine and Pharmacotherapy 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-79959676872&doi=10.1016%2fj.biopha.2011.04.001&partnerID=40&md5=611bb93d7b0850d37b67ef43d04738ac  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1016/j.biopha.2011.04.001  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_07533322_v65_n3_p210_FernandezCalienes  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_07533322_v65_n3_p210_FernandezCalienes  |y Registro en la Biblioteca Digital 
961 |a paper_07533322_v65_n3_p210_FernandezCalienes  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 71544